The Efficacy of Prophylactic TAF for HBsAg-positive Patients Receiving bDMARDs
Clinical trial NCT05001672 · UNKNOWN
Trial details
- NCT number
- NCT05001672
- Sponsor
- Taipei Veterans General Hospital, Taiwan
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-15
- Primary completion
- 2025-06-30
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.